News | July 11, 2014

Cyclotron Arrival Marks Milestone in Construction of Advanced Cancer Treatment Center

July 11, 2014 — The Texas Center for Proton Therapy received its new cyclotron this month, and the center is expected to treat its first patients in early 2016. The center is a collaboration of Texas Oncology, the US Oncology Network and McKesson Specialty Health.

The new cyclotron is the only second-generation proton therapy technology in Texas and is the centerpiece of the Irving-Las Colinas facility. The cyclotron, a magnet-packed particle accelerator, creates protons that travel up to two-thirds the speed of light through a 143-foot beamline – nearly half the length of a football field – to the patient’s tumor with pinpoint accuracy.

The therapy is especially beneficial for treating cancers requiring extreme precision such as tumors in the brain, eye, spine, head and neck, as well as pediatric patients. The beam’s exceptional accuracy minimizes side effects and damage to surrounding healthy tissue and enables patients to maintain their quality of life during and after treatment.

“Texas Oncology is excited to bring this remarkable technology to the area to help create more cancer survivors. The size and weight of the cyclotron belie the precision that this form of radiation treatment delivers in destroying cancer cells,” said Steven Paulson, M.D., chairman and president of Texas Oncology. “The proton therapy center reaffirms our commitment to create more hope for cancer patients by adding leading-edge technology to complement the existing array of advanced cancer treatment choices for the 119,000 Texans that will be diagnosed with cancer this year.”

The arrival of the cyclotron marks the end of a complex, month-long odyssey for the equipment. Manufactured by Ion Beam Applications S.A. in Belgium, the 220-ton cyclotron was shipped in two sections, bolted to the hull of the ship to balance the unusually heavy cargo and to prevent capsizing. After more than 5,000 miles at sea, the cyclotron traveled from the Port of Houston to Irving by land, on two 19-axle trucks via an indirect route due to its massive size and weight. A specialized crane then carefully hoisted it into place in the facility.

“The delivery of the cyclotron is an impressive logistical feat that signifies an important construction milestone. We’re pleased to have completed one more step in bringing this advanced treatment to North Texas,” said Kirk Kaminsky, president of the US Oncology Network and provider services for McKesson Specialty Health.

Although physical construction of the center, with a fixed beam and two isocentric gantry treatment rooms, is more than 80 percent complete, highly technical work will fill the next several months as the advanced technology behind the lifesaving treatment is carefully set, calibrated and tested.

“Physicists and engineers from IBA and Texas Oncology physicists will be on site to manage the meticulous calibration and testing of the proton beam equipment,” said Gary Barlow, director of the Texas Center for Proton Therapy. “What makes this therapy so effective is its extraordinary precision in targeting the proton beams on the tumor. To do that, we have to calibrate the machine to submillimeter accuracy.”

For more information: www.texascenterforprotontherapy.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init